Catalyst Wire Dossier Catalyst Wire Dossier

Dual antiplatelet therapy (aspirin + P2Y12 inhibitor)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dual antiplatelet therapy (aspirin + P2Y12 inhibitor), covering 2025-04-02 to 2025-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction [Phase 4]

See pricing